The London School of Hygiene & Tropical Medicine has announced grants totaling almost $60 million from the Bill & Melinda Gates Foundation and other funders to help find new and effective ways of treating and preventing malaria, HIV/AIDS, and tuberculosis.
The foundation awarded nearly $40 million over four years to LSHTM in support of the ACT Consortium, which includes almost fifty academic institutions in Africa, Asia, Europe, and the United States. With the funds, the consortium will conduct a coordinated research program to identify ways to optimize the delivery and cost-effectiveness of combination drug treatment for malaria in Africa and Asia as well as across a range of epidemiological and healthcare settings.
The school was also awarded a separate $3 million grant from the foundation for research on seasonal intermittent treatment of malaria in children; $986,000 from the University of Dakar for a project to implement intermittent preventive treatment (IPTP) in Senegal; and $7.6 million through the Malaria in Pregnancy Consortium in support of four major activities, including a multi-center trial based in India and countries in Southeast Asia comparing the safety and efficacy of two new antimalarial drug combinations during pregnancy.
In addition, LSHTM will receive a two-year, $3.6 million grant from the Gates Foundation to develop a reporter imaging system to test the efficacy of TB drugs, and $5 million from the International Planned Parenthood Federation for research into the benefits and costs of a range of models for delivering integrated HIV and sexual reproductive health services in Kenya and Swaziland.
"I am delighted to announce these awards to staff of the school, which reflect both the excellence of the proposed research programs and their relevance to global health priorities," said LSHTM director Sir Andrew Haines. "They will generate important new knowledge to improve the prospects for effective treatment and prevention of malaria, TB, and HIV...and build on the major achievements arising from previous research at LSHTM."